Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hayden

Showing results (381-390 of 391) with videos related to

Pageof 40
Sort By:
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Intensive Care Medicine|March 31, 2020
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
Critical Care Medicine|April 1, 2020
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
The Lancet. Infectious Diseases|December 21, 2013
Open source clinical science for emerging infectionsJake W Dunning, Laura Merson, Gernot G U Rohde, et al.
The New England Journal of Medicine|October 7, 2020
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory SyndromeYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Trials|January 5, 2020
Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trialYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Lancet (London, England)|May 20, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialYeming Wang, Dingyu Zhang, Guanhua Du, et al.
Science (New York, N.Y.)|April 20, 2013
Reorganization of Southern Ocean plankton ecosystem at the onset of Antarctic glaciationAlexander J P Houben, Peter K Bijl, Jörg Pross, et al.
Critical Care Medicine|February 8, 2021
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First UpdateWaleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Pageof 40

Showing results (381-390 of 391) with videos related to

Sort By:
Pageof 40
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Intensive Care Medicine|March 31, 2020
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
Critical Care Medicine|April 1, 2020
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
The Lancet. Infectious Diseases|December 21, 2013
Open source clinical science for emerging infectionsJake W Dunning, Laura Merson, Gernot G U Rohde, et al.
The New England Journal of Medicine|October 7, 2020
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory SyndromeYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Trials|January 5, 2020
Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trialYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Lancet (London, England)|May 20, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialYeming Wang, Dingyu Zhang, Guanhua Du, et al.
Science (New York, N.Y.)|April 20, 2013
Reorganization of Southern Ocean plankton ecosystem at the onset of Antarctic glaciationAlexander J P Houben, Peter K Bijl, Jörg Pross, et al.
Critical Care Medicine|February 8, 2021
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First UpdateWaleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Pageof 40